Evidence map›Paper›PMID 42506284›Full record

ArticleJournal of fungi (Basel, Switzerland)2026

In Vitro Anti-

Xihua Lian, Amy Scott-Thomas, John G Lewis, Madhav Bhatia, Stephen T Chambers

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xihua LianDepartment of Ultrasound Medicine, Second Clinical Medical School, Fujian Medical University, Quanzhou 362000, China.
Amy Scott-ThomasDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand.ORCID 0000-0002-3246-2491
John G LewisDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand.
Madhav BhatiaDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand.
Stephen T ChambersDepartment of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand.ORCID 0000-0002-0698-3285

Funding

Joint Funds for the Innovation of Science and Technology, Fujian province 2023Y9264McGee Fellowship 2023 N/AOtago Research Grant 21943University of Otago Sandy Smith Scholarship/Grants-in-Aid N/A
6 · The paper itself

Abstract

objectiveTo determine the in vitro anti-

methodsThe in vitro antifungal activity of 1D2, 4E4 and all antifungal drugs was determined in a microplate-based assay. The anti-

resultsThe in vitro interactions of 1D2 with voriconazole, posaconazole, amphotericin B and caspofungin against four different

conclusionsIn this study, 1D2 and 4E4 showed in vitro growth-inhibitory activity against the tested

Indexed as

1D24E4antifungal agentsAspergillus infectioninvasive aspergillosismonoclonal antibody

Identifiers

PMID42506284
PMCPMC13412620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.